Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
While Phase 2 trials for Retatrutide showed promising results, the molecule is still being audited for long-term effects
This article is for the cash payers the patients who started in January for $149 a month and are now staring at a $299 monthly bill at maintenance doses
Coverage may depend on medical necessity, medication benefits, diagnosis, and plan-specific exclusions
The combination of both mechanisms produces the total 57 bpm increase seen with retatrutide
These statements have not been evaluated by the FDA and the compound is not intended to diagnose, treat, cure, or prevent any disease
If any oral hypoglycemics are used during breastfeeding, the nursing infant should be monitored for signs of hypoglycemia, such as increased fussiness or somnolence
US$ 29.11
US$ 21.46
US$ 27.83
US$ 29.29
US$ 20.65
